Brochure
13 Feb 2019

API development and manufacturing presentation

PDF 4.4 MB

API development and manufacturing presentation. Link to video material.

Content provided by our supplier

Orion Corporation

  • FI
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer

Other Content from Orion Corporation (1)

  • News Bayer and Orion (Fermion) experiences in development of API process for Darolutamide

    The compound was first synthesized and developed by Orion, who partnered it with Bayer for Phase III clinical development. Bayer holds the global marketing rights, while Orion and its subsidiary Fermion handle all the CMC and manufacturing activities from early clinical development to commercial production. Orion manufactures the drug products, while Fermion manufactures the Darolutamide API. Orion holds co-promotion rights for Europe.